冠状母细胞瘤中的恶性转变 - 它是否存在?
1Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute University, Mumbai, Maharashtra, India.
International journal of surgical pathology
|May 23, 2024
概括
罕见的骨瘤 - - 冠状母细胞瘤的恶性转变非常罕见. 这种病例突出显示了一种具有H3K36M免疫覆盖的质母细胞瘤,进化为高等级的肉瘤.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 骨瘤 骨瘤是指骨上的瘤.
背景情况:
- 冠状母细胞瘤通常是一种良性骨瘤.
- 恶性冠状母细胞瘤是极其罕见的和争论.
- 已经记录了复发和转移的形式.
研究的目的:
- 为了描述一种罕见的恶性转变的案例,在一个chondroblastoma.
- 调查这种转变的组织病理学和免疫组织化学特征.
- 为了解恶性冠状母细胞瘤进化的理解做出贡献.
主要方法:
- 骨瘤活检的组织病理学检查.
- 免疫组织化学分析包括H3K36M,DOG1,SATB2和desmin.
- 损伤的放射性评估. 损伤的放射性评估.
主要成果:
- 鉴定了一种具有明显高等级肉瘤焦点的冠状腺母细胞瘤.
- 整个瘤显示H3K36M阳性.
- DOG1突出显示了冠状母细胞瘤区域,而SATB2和desmin突出显示了肉瘤区域.
结论:
- 这些发现支持了体母细胞瘤中恶性转变的存在.
- H3K36M免疫染可能是这些罕见瘤的关键标志物.
- 这一案例强调了彻底的组织病理学和免疫组织化学评估对于准确的诊断和预后的重要性.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer
48.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.4K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


